Source:http://linkedlifedata.com/resource/pubmed/id/11794901
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2002-1-17
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0248-8663
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1271-2
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11794901-Adjuvants, Immunologic,
pubmed-meshheading:11794901-Adult,
pubmed-meshheading:11794901-Follow-Up Studies,
pubmed-meshheading:11794901-Humans,
pubmed-meshheading:11794901-Interferon-beta,
pubmed-meshheading:11794901-Male,
pubmed-meshheading:11794901-Multiple Sclerosis,
pubmed-meshheading:11794901-Purpura, Thrombocytopenic, Idiopathic,
pubmed-meshheading:11794901-Time Factors
|
pubmed:year |
2001
|
pubmed:articleTitle |
[Association of multiple sclerosis and autoimmune thrombopenia].
|
pubmed:publicationType |
Letter,
Case Reports
|